It’s a loaded question, given that venture capitalists invested far less in the Pacific Northwest in 2018 than leading regions in terms of total investment, number of deals and deal size.
The average deal size in San Francisco and New England last year was around $60 million, double the roughly $30 million average that Northwest companies saw, according to data presented by Karen Bernstein, co-founder of BioCentury, at the 2019 Life Science Innovation Northwest conference in Seattle earlier this week.
Despite this, Seattle and the Pacific Northwest are seen as an emerging hotspot for the sector. At the conference, venture capital and angel investors offered their view on the region’s ability to compete with leading markets like the Bay Area and Cambridge, Mass. Here’s what they said.
